126 related articles for article (PubMed ID: 37558545)
21. Tacrolimus monitoring in renal transplantation: a comparison between high-performance liquid chromatography and immunoassay.
Borrows R; Chusney G; Loucaidou M; Singh S; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
Transplant Proc; 2005 May; 37(4):1733-5. PubMed ID: 15919448
[TBL] [Abstract][Full Text] [Related]
22. Comparison of 4 Commercial Immunoassays Used in Measuring the Concentration of Tacrolimus in Blood and Their Cross-Reactivity to Its Metabolites.
Shigematsu T; Suetsugu K; Yamamoto N; Tsuchiya Y; Masuda S
Ther Drug Monit; 2020 Jun; 42(3):400-406. PubMed ID: 31568181
[TBL] [Abstract][Full Text] [Related]
23. A rapid, simple and sensitive liquid chromatography-tandem mass spectrometry method for routine clinical monitoring of tacrolimus with the Waters Masstrak™ immmunosuppressant kit.
Guilhaumou R; Lacarelle B; Sampol-Manos E
Methods Find Exp Clin Pharmacol; 2010 Dec; 32(10):737-43. PubMed ID: 21225010
[TBL] [Abstract][Full Text] [Related]
24. Analytical and clinical validation of dried blood spot and volumetric absorptive microsampling for measurement of tacrolimus and creatinine after renal transplantation.
Mathew BS; Mathew SK; Aruldhas BW; Prabha R; Gangadharan N; David VG; Varughese S; John GT
Clin Biochem; 2022; 105-106():25-34. PubMed ID: 35490728
[TBL] [Abstract][Full Text] [Related]
25. Quantification of tacrolimus and three demethylated metabolites in human whole blood using LC-ESI-MS/MS.
Dubbelboer IR; Pohanka A; Said R; Rosenborg S; Beck O
Ther Drug Monit; 2012 Apr; 34(2):134-42. PubMed ID: 22406653
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of A Liquid Chromatography-Tandem Mass Spectrometry Method to Simultaneously Measure Tacrolimus and Everolimus Concentrations in Kidney Allograft Biopsies After Kidney Transplantation.
Zhang M; Tajima S; Shigematsu T; Noguchi H; Kaku K; Tsuchimoto A; Okabe Y; Egashira N; Ieiri I
Ther Drug Monit; 2022 Apr; 44(2):275-281. PubMed ID: 34224536
[TBL] [Abstract][Full Text] [Related]
27. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
Westley IS; Taylor PJ; Salm P; Morris RG
Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
[TBL] [Abstract][Full Text] [Related]
28. Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography-electrospray mass spectrometry with the enzyme multiplied immunoassay technique.
Ansermot N; Fathi M; Veuthey JL; Desmeules J; Rudaz S; Hochstrasser D
Clin Biochem; 2008 Jul; 41(10-11):910-3. PubMed ID: 18358833
[TBL] [Abstract][Full Text] [Related]
29. Paxlovid-tacrolimus drug-drug interaction caused severe diarrhea that induced combined diabetic ketoacidosis and a hyperglycemic hyperosmolar state in a kidney transplant patient: a case report.
Luo W; He Y; Wei MG; Lu GB; Yi Q
J Med Case Rep; 2023 Sep; 17(1):406. PubMed ID: 37742028
[TBL] [Abstract][Full Text] [Related]
30. A specific method for the measurement of tacrolimus in human whole blood by liquid chromatography/tandem mass spectrometry.
Zhang Q; Simpson J; Aboleneen HI
Ther Drug Monit; 1997 Aug; 19(4):470-6. PubMed ID: 9263391
[TBL] [Abstract][Full Text] [Related]
31. Paxlovid-Tacrolimus Drug-Drug Interaction in a 23-Year-Old Female Kidney Transplant Patient with COVID-19.
Berar Yanay N; Bogner I; Saker K; Tannous E
Clin Drug Investig; 2022 Aug; 42(8):693-695. PubMed ID: 35816278
[No Abstract] [Full Text] [Related]
32. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
[TBL] [Abstract][Full Text] [Related]
33. Liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants and creatinine from a single dried blood spot using the Capitainer® qDBS device.
Deprez S; Van Uytfanghe K; Stove CP
Anal Chim Acta; 2023 Feb; 1242():340797. PubMed ID: 36657891
[TBL] [Abstract][Full Text] [Related]
34. Lack of concordance between EMIT assay and LC-MS/MS for Therapeutic Drug Monitoring of Mycophenolic Acid: Potential increased risk for graft rejection?
De Nicolò A; Ianniello A; Benagli C; Della Bruna R; Keller F; Antonucci M; D'Avolio A; Cantù M
J Pharm Biomed Anal; 2020 Aug; 187():113337. PubMed ID: 32442868
[TBL] [Abstract][Full Text] [Related]
35. Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II).
Armstrong VW; Schuetz E; Zhang Q; Groothuisen S; Scholz C; Shipkova M; Aboleneen H; Oellerich M
Clin Chem; 1998 Dec; 44(12):2516-23. PubMed ID: 9836720
[TBL] [Abstract][Full Text] [Related]
36. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry.
Peake RW; Hartigan CR; Esposito CL; Kellogg MD; Gabler J; Wang S; Breaud A; Di Bussolo J; Moskowitz J; Clarke W
Ther Drug Monit; 2015 Apr; 37(2):161-71. PubMed ID: 25072947
[TBL] [Abstract][Full Text] [Related]
37. Drug-drug interaction between paxlovid and tacrolimus in a patient with myasthenia gravis and SARS-CoV-2 infection.
Chen Y; Wan W; Yao X; Guan Y
J Neuroimmunol; 2023 Dec; 385():578245. PubMed ID: 37992586
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Waters MassTrak LC-MS/MS Assay for Tacrolimus and a Comparison to the Abbott Architect Immunoassay.
Saitman A; Metushi IG; Mason DS; Fitzgerald RL
Ther Drug Monit; 2016 Jun; 38(3):300-4. PubMed ID: 26473523
[TBL] [Abstract][Full Text] [Related]
39. Tacrolimus Metabolite M-III May Have Nephrotoxic and Myelotoxic Effects and Increase the Incidence of Infections in Kidney Transplant Recipients.
Zegarska J; Hryniewiecka E; Zochowska D; Samborowska E; Jazwiec R; Borowiec A; Tszyrsznic W; Chmura A; Nazarewski S; Dadlez M; Paczek L
Transplant Proc; 2016 Jun; 48(5):1539-42. PubMed ID: 27496443
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
